Pabau GO app

The new Pabau GO is heredownload on the App Store

Download on the App Store
Book a demo Book a demo
Billing Codes

HCPCS Code G0145: Screening cytopathology, cervical or vaginal, thin-layer

Key Takeaways

Key Takeaways

HCPCS Code G0145 describes screening cytopathology, cervical or vaginal, collected in preservative fluid, automated thin-layer preparation, with automated system screening and manual rescreening under physician supervision.

Medicare covers G0145 once every 24 months for average-risk women and once every 12 months for high-risk women or women of childbearing age with a prior negative Pap test within the last 3 years.

The most common denial triggers for G0145 are frequency violations, mismatched ICD-10 diagnosis codes, and missing physician supervision documentation – none of which standalone code-lookup tools flag before submission.

Pabau’s claims management software helps OB/GYN practices and clinical labs catch G0145 billing errors before submission with built-in claim scrubbing, modifier prompts, and automated fee schedule updates.

HCPCS Code G0145: definition and clinical description

Most cervical cytology claims denied by Medicare come down to one thing: the wrong code. The G-series pap smear codes look similar on the surface, but each captures a distinct specimen collection method and laboratory workflow. Selecting the wrong one costs the practice the claim.

HCPCS Code G0145 is a Healthcare Common Procedure Coding System (HCPCS) Level II code maintained by the Centers for Medicare and Medicaid Services (CMS). It describes screening cytopathology, cervical or vaginal, collected in preservative fluid, automated thin-layer preparation, with automated system screening and manual rescreening under physician supervision. For OB/GYN practice management software users, G0145 is one of the most frequently billed laboratory codes in preventive women’s health.

In plain terms: the clinician collects a cervical or vaginal specimen into a liquid preservative vial (such as ThinPrep by Hologic or SurePath by BD Diagnostics). The laboratory processes it into an automated thin-layer slide, runs the slide through an automated screening system, then a cytotechnologist or pathologist manually rescreens it under physician supervision. G0145 captures all three steps as a single billable unit.

G0145 code details at a glance

The table below gives the quick-reference fields billing staff need before touching the claim form. All information reflects the current active code status.

Field Value
HCPCS Code G0145
Short descriptor Scr c/v cyto, thinlayer, rescr
Long descriptor Screening cytopathology, cervical or vaginal, any reporting system, collected in preservative fluid, automated thin-layer preparation, with screening by automated system and manual rescreening under physician supervision
Code type HCPCS Level II (G-code)
Fee schedule category Medicare Clinical Laboratory Fee Schedule (CLFS)
Effective date 2005 (active)
Status Active – billable for current dates of service
Primary billers Clinical laboratories, OB/GYN practices, women’s health clinics

G0145 Medicare fee schedule and reimbursement rates (2026)

G0145 is paid under the Medicare Clinical Laboratory Fee Schedule (CLFS), not the Physician Fee Schedule. The CLFS sets a national limitation amount (NLA) that acts as a payment ceiling; Medicare contractors may not pay above it. Rates are adjusted annually through the CMS final rule process.

The 2026 national limitation amount for G0145 has not been published in a final rule available at the time of this writing. Use the CMS Physician Fee Schedule and CLFS lookup tool to verify the current year’s rates before submitting claims. As a reference point, G0145 has historically reimbursed in the range of $20 to $35 nationally, though geographic adjustments apply.

Rate type Notes
National limitation amount (NLA) Published annually by CMS in the CLFS final rule. Verify at cms.gov before billing.
Facility vs non-facility CLFS codes do not distinguish facility/non-facility rates the way the Physician Fee Schedule does. The NLA applies regardless of place of service.
Geographic adjustment CLFS rates are nationally uniform; geographic adjustments are minimal compared to Part B physician services.
Patient cost-sharing Medicare covers preventive pap smears at 100% – no deductible or coinsurance for eligible beneficiaries under Part B preventive benefit.

Medicare coverage and eligibility for G0145

According to CMS MLN909032 (Screening Pap Tests and Pelvic Exams), Medicare Part B covers screening Pap tests for the early detection of cervical and vaginal cancer. Coverage frequency depends on the patient’s risk category.

Frequency limitations

Patient category Coverage frequency Key condition
Average-risk women Once every 24 months No high-risk factors present
High-risk women Once every 12 months High-risk factors documented in medical record
Childbearing-age women Once every 12 months Had a negative Pap test within the previous 3 years

High-risk factors recognized by CMS include prior cervical cancer, history of abnormal Pap results, sexually transmitted infections, other high-risk conditions, and certain lifestyle factors documented by the ordering physician. The high-risk determination must appear in the medical record to support the 12-month frequency.

Medicare Advantage (Part C) plans are required to cover preventive pap smear screening at parity with traditional Medicare. The Affordable Care Act (ACA) preventive services mandate additionally requires most commercial insurers to cover cervical cancer screening without cost-sharing, though code-specific coverage rules vary by payer.

ICD-10-CM diagnosis codes to use with HCPCS Code G0145

A clean G0145 claim requires a supporting ICD-10-CM diagnosis code that confirms the screening indication. Mismatched or unsupported diagnosis codes are a top denial driver. Use the codes below as a starting reference; verify against the current CMS crosswalk and your MAC’s local coverage determination before billing.

ICD-10-CM code Description Use context
Z12.4 Encounter for screening for malignant neoplasm of cervix Routine cervical cancer screening, average-risk patient
Z01.419 Encounter for gynecological examination (general) (routine) without abnormal findings Routine GYN exam with pap collection, no abnormal findings
Z01.411 Encounter for gynecological examination (general) (routine) with abnormal findings GYN exam where abnormal findings are identified during the visit
Z12.72 Encounter for screening for malignant neoplasm of vagina Vaginal cytology screening (post-hysterectomy or other indication)
Z77.010 Contact with and (suspected) exposure to arsenic Not applicable – included here as a negative example: never use non-screening codes to support a G0145 claim

For high-risk patients receiving annual screening, confirm the diagnosis code reflects the documented high-risk factor. Using Z12.4 alone on a claim billed at the 12-month frequency may trigger a frequency-limit edit if the payer’s system cannot identify the high-risk justification from the diagnosis alone. Documenting the specific risk factor in the record and selecting the most specific ICD-10 code available strengthens the claim.

See the clinical documentation best practices guide for how to structure patient records to support preventive screening claims and reduce audit exposure. Maintaining structured digital records is also a key requirement under HIPAA compliance requirements for medical offices.

Applicable modifiers for G0145

Modifier selection for G0145 determines whether the technical component, professional component, or complete service is being billed. An incorrect or missing modifier is one of the fastest ways to generate a denial or an overpayment audit flag.

Modifier Description When it applies
QW CLIA-waived test Use when the test is performed in a CLIA-waived laboratory. Note: standard cytopathology is typically performed in CLIA-certified (non-waived) labs; verify CLIA certificate category before applying QW to G0145.
26 Professional component When the physician bills separately for interpretation and supervision only (lab performs the technical work). Used when the physician and lab bill independently.
TC Technical component When the laboratory bills for specimen processing and automated screening only, without the professional reading component.

When the same entity performs both the technical and professional work (the complete service), no modifier is appended and the full NLA is billed. Splitting the global service into TC and 26 should only occur when two separate entities genuinely perform the two components. Splitting incorrectly is a common audit target.

Place of service and billing settings for G0145

G0145 is almost always billed by the clinical laboratory that processes the specimen, not by the clinician who collected it. Understanding place-of-service (POS) codes matters for accurate claim submission and rate calculation.

  • POS 81 (Independent Laboratory): The most common setting for G0145 billing. The reference lab processes the ThinPrep or SurePath specimen and bills Medicare directly.
  • POS 11 (Office): Used when an OB/GYN practice operates an in-house laboratory that performs the full cytology preparation and screening in-office. The practice must hold the appropriate CLIA certificate for non-waived lab testing.
  • POS 22 (On Campus Outpatient Hospital): Used when the specimen is processed by a hospital-based outpatient lab. Note that hospital outpatient billing follows separate claim form and revenue code rules.
  • POS 19 (Off Campus Outpatient Hospital): Applies to off-campus hospital outpatient departments.

The collecting clinician (the OB/GYN or primary care physician) does not typically bill G0145. The clinician bills for the office visit and specimen collection using the appropriate E&M and collection codes. G0145 travels to the laboratory with the requisition and becomes the lab’s claim. This split-billing workflow is a common source of confusion for practices that have recently brought cytology processing in-house.

Pro Tip

If your OB/GYN practice recently started billing G0145 in-house, confirm your CLIA certificate number is enrolled with your Medicare Administrative Contractor (MAC) before submitting claims. Missing or incorrect CLIA enrollment is one of the fastest routes to a blanket laboratory claim rejection.

The G-series cytopathology codes are the primary source of mis-billing on cervical screening claims. Each code represents a specific combination of collection method, preparation technique, and screening protocol. Picking the wrong one is not a technicality – payers audit for code-to-service mismatches, and the difference between G0145 and G0123 is real and auditable.

Code Short description Collection method Screening type Key differentiator
G0123 Scr c/v cyto, thinlayer Preservative fluid (liquid-based) Manual screen only No automated system; cytotechnologist screens manually without automated pre-screen
G0124 Scr c/v cyto, thinlayer, md Preservative fluid (liquid-based) Manual screen by MD/DO Physician directly performs manual screening (not delegated to cytotechnologist)
G0141 Scr cyto, c/v, auto, rescreen Conventional smear (not liquid-based) Automated with rescreening Conventional (non-liquid) smear prep; automated screening with physician-supervised rescreening
G0143 Scr cyto, c/v, thinlayer, rescr Preservative fluid (liquid-based) Manual rescreening only Liquid-based; rescreened manually without initial automated pass
G0144 Scr cyto, c/v, thinlayer, auto Preservative fluid (liquid-based) Automated only (no rescreening) Automated system screens the slide; no physician-supervised manual rescreening step
G0145 Scr c/v cyto, thinlayer, rescr (auto + manual) Preservative fluid (liquid-based) Automated + manual rescreening This code: liquid-based, automated system screen PLUS physician-supervised manual rescreening
G0147 Scr cyto smear, c/v, auto Conventional smear Automated only Conventional smear processed by automated system; no rescreening and no liquid-based prep
G0148 Scr cyto smear, c/v, rescr Conventional smear Manual rescreening Conventional smear with manual physician-supervised rescreening; no automated system used

G0145 vs G0123 in practice: Both use liquid-based collection. The difference is the screening protocol. G0123 uses manual screening only. G0145 adds an automated system pass before the manual rescreening. If your laboratory runs specimens through an automated screening device (such as ThinPrep Imaging System) and then has a cytotechnologist manually review, G0145 is correct. If the lab uses only manual cytotechnologist screening, G0123 applies.

For related reproductive health procedure coding, see our guide to IVF procedure billing codes.

Stop chasing G0145 denials after the fact

Pabau's built-in claims management tools flag frequency violations, mismatched diagnosis codes, and missing modifiers before you submit. OB/GYN practices and clinical labs use Pabau to keep cervical screening claims clean from the first submission.

Pabau claims management dashboard

Documentation requirements for G0145

The record must demonstrate that the service described by G0145 actually occurred. Medicare auditors review laboratory requisitions, physician orders, and chart notes to confirm code-to-service alignment. Missing any of the following elements is enough to trigger a recoupment demand.

  • Physician order or standing order: The ordering physician must have directed the cervical cytology screening. A standing order for annual preventive GYN exams can satisfy this, but it must be dated and signed.
  • Lab requisition with specimen type noted: The requisition must indicate that the specimen was collected in a liquid preservative vial (e.g., ThinPrep or SurePath). “Cervical swab” without noting preservative fluid is insufficient for G0145 specifically.
  • Documentation of automated system use: The laboratory’s internal accession record or pathology report should note that the slide was processed using an automated screening system. If the lab did not run an automated pass, G0145 is not the correct code.
  • Physician supervision notation: The pathology report or laboratory log must indicate that manual rescreening was performed under physician supervision. A supervising pathologist’s signature or co-sign satisfies this requirement.
  • Patient eligibility confirmation: For high-risk frequency claims (12-month billing), the medical record must document the specific high-risk factor. A risk-factor checklist or structured note in the chart provides this.
  • ABN if applicable: If Medicare is expected to deny the claim (e.g., frequency limit not yet met), an Advance Beneficiary Notice of Noncoverage (ABN) must be obtained and on file before service is rendered.

Practices using digital patient intake forms can embed a structured cervical screening risk-factor assessment directly into the intake workflow, capturing the high-risk documentation automatically at the point of care rather than hunting for it during an audit. This approach aligns with broader HIPAA compliance requirements for medical offices around structured documentation.

Medical Forms New Medical Form With Components@2x
Medical Forms New Medical Form With Components@2x

Common billing errors and denial prevention for HCPCS Code G0145

None of the top-ranking code reference pages for G0145 address denial prevention. This section covers the five errors that generate the most G0145 rejections, what causes each one, and how to prevent it before the claim leaves the practice.

Error type What causes it Prevention
Frequency violation Billing at 12-month intervals without documenting high-risk status; average-risk patient screened before 24 months Build a last-pap-date check into the scheduling workflow; flag patients approaching but not yet at their coverage date
Mismatched diagnosis code Using a non-screening ICD-10 code (e.g., a symptom code) when the visit was purely preventive; using Z01.419 when abnormal findings were present Train staff on the distinction between screening (Z12.4) and diagnostic visits; implement claim scrubbing rules that flag G0145 billed with symptom-only diagnoses
Wrong pap smear G-code Billing G0145 when the lab used conventional (non-liquid) smear prep, or when no automated system was used Confirm specimen type and lab protocol with the reference lab before billing; use the G-code comparison table above as a checklist
Missing physician supervision documentation G0145 requires physician-supervised manual rescreening; if the pathology report does not document this, the code is unsupported Require the reference lab to include physician supervision notation on all G0145 reports returned to your practice
Duplicate billing with CPT equivalents Some practices inadvertently bill both a CPT cytopathology code (e.g., 88142) and G0145 for the same specimen when both the lab and the physician office bill independently Establish a clear billing agreement with your reference lab specifying who bills the global service vs split TC/26 components; never bill both a HCPCS G-code and its CPT equivalent for the same specimen

How practice management software simplifies HCPCS Code G0145 billing

Standalone code-lookup tools give you the description and the fee schedule. They do not verify frequency limits against the patient’s last service date, flag diagnosis mismatches, or prompt for missing modifiers before the claim goes out. That gap is where G0145 denials live.

Pabau’s claims management software is built for clinical practices that need HCPCS billing integrated with patient records, not bolted on afterward. Key capabilities relevant to G0145 workflows include:

Fully Integrated with Pabau Billing
Fully Integrated with Pabau Billing
  • Pre-submission claim scrubbing: Built-in edits flag mismatched diagnosis codes, frequency-limit conflicts, and missing modifier entries before the claim is transmitted.
  • Automated fee schedule updates: CMS publishes CLFS updates annually. Pabau pushes fee schedule changes automatically, so the 2026 rate for G0145 is reflected in the system without manual intervention.
  • HCPCS code library: G0145 and the full G-series pap smear codes are searchable within the platform, reducing the risk of selecting an adjacent code (G0123, G0144) when the service warrants G0145.
  • Structured documentation: The automated billing workflows connect the clinical note, specimen requisition, and claim in one audit trail.

For OB/GYN and women’s health practices that bill preventive pap smears alongside a broader gynecology service mix, Pabau’s sexual and reproductive health clinic software integrates scheduling, clinical documentation, and billing in one platform. Practices managing multi-payer environments can also use Pabau’s practice management software to standardize code selection and documentation across providers.

For healthcare compliance workflows, having billing and documentation in a single system also simplifies internal audits.

Conclusion

HCPCS Code G0145 is the correct billing code when a cervical or vaginal specimen is collected in a liquid preservative, processed through automated thin-layer preparation, screened by an automated system, and manually rescreened under physician supervision. Getting that specific combination right on every claim requires more than a code-lookup page.

Frequency violations, diagnosis mismatches, and undocumented physician supervision are the three denial triggers that most practices do not catch until the remittance arrives. Pabau’s built-in claim scrubbing catches these before submission. To see how it works for your OB/GYN or women’s health practice, book a demo.

Continue your research

Continue your research

Need a complete OB/GYN billing and documentation platform? OB/GYN EMR software by Pabau covers scheduling, clinical records, and claims in one integrated workflow for women’s health practices.

Billing multiple procedure codes across a preventive care visit? Pabau’s claims management software connects diagnosis codes, modifiers, and HCPCS codes in a single pre-submission scrub.

Managing digital forms and intake documentation for GYN patients? Digital forms for healthcare practices lets you embed structured risk-factor assessments directly into the patient intake flow.

Frequently Asked Questions

What is HCPCS Code G0145 used for?

HCPCS Code G0145 is used to bill for screening cytopathology of a cervical or vaginal specimen that was collected in a liquid preservative, processed using automated thin-layer preparation, screened by an automated system, and manually rescreened under physician supervision. It applies to liquid-based pap tests (such as ThinPrep or SurePath) that go through both an automated and a physician-supervised manual screening step.

What is the Medicare reimbursement rate for G0145?

G0145 is paid under the Medicare Clinical Laboratory Fee Schedule (CLFS) at a nationally set rate (the national limitation amount). Historically this has ranged from approximately $20 to $35, though the exact 2026 figure must be verified against the current CMS CLFS final rule at cms.gov before billing, as rates are updated annually.

What is the difference between G0145 and G0123?

Both G0123 and G0145 use liquid-based cervical cytology collection in a preservative fluid. The difference is the screening protocol: G0123 uses manual cytotechnologist screening only, while G0145 adds an automated system pre-screen followed by physician-supervised manual rescreening. If your laboratory runs specimens through an automated screening device (such as ThinPrep Imaging System) before manual review, G0145 is the correct code. If only manual screening occurs, use G0123.

How often does Medicare cover G0145 pap smear screening?

Medicare covers G0145 once every 24 months for average-risk women and once every 12 months for high-risk women or women of childbearing age who have had a negative Pap test in the previous 3 years. The high-risk determination must be documented in the medical record to support the 12-month billing frequency.

What diagnosis codes are used with G0145?

The most commonly paired ICD-10-CM codes are Z12.4 (screening for malignant neoplasm of cervix) for routine average-risk screening, Z01.419 (routine gynecological examination without abnormal findings), and Z12.72 (screening for malignant neoplasm of vagina) for post-hysterectomy vaginal cytology screening. High-risk patients should have a more specific diagnosis code reflecting the documented risk factor.

What is the place of service for G0145 billing?

G0145 is most commonly billed with Place of Service 81 (Independent Laboratory), as the reference lab typically processes the specimen and submits the claim directly to Medicare. OB/GYN practices with an in-house laboratory may use POS 11 (Office), provided the practice holds the appropriate CLIA certificate for non-waived laboratory testing.

×